(en) Department of Research and Development, BIAL-Portela and Co., « Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects », Drugs in R&D, no 4, , p. 225-242 (ISSN1174-5886, lire en ligne, consulté le ).
(en) Department of Research and Development, BIAL-Portela and Co., « Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects », Drugs in R&D, no 4, , p. 225-242 (ISSN1174-5886, lire en ligne, consulté le ).